{"disease":{"id":"mers-middle-east-respiratory-syndrome","name":"mers middle east respiratory syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04128059","title":"Study of Safety and Immunogenicity of BVRS-GamVac-Combi","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":268,"lead_sponsor_name":"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation","has_results":false},{"nct_id":"NCT04130594","title":"Study of Safety and Immunogenicity of BVRS-GamVac","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":162,"lead_sponsor_name":"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation","has_results":false},{"nct_id":"NCT04119440","title":"Safety and Immunogenicity of the Candidate Vaccine MVA-MERS-S_DF-1 Against MERS","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":145,"lead_sponsor_name":"Universitätsklinikum Hamburg-Eppendorf","has_results":false},{"nct_id":"NCT03399578","title":"Safety and Immunogenicity of a Candidate MERS-CoV Vaccine (MERS001)","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":29,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT03615911","title":"Safety, Tolerability and Immunogenicity of Vaccine Candidate MVA-MERS-S","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Marylyn Addo","has_results":true}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}